Chongqing Dikang Erle Pharmaceutical

Chongqing Dikang Erle Pharmaceutical is a specialized pharmaceutical manufacturer based in Chongqing, China, and a key subsidiary of the Sichuan Dikang Pharmaceutical Group. Following the acquisition of its parent group by Haisco Pharmaceutical Group in 2020, the company has continued to focus on the production of high-quality chemical drugs and traditional Chinese medicine (TCM) formulations. Its core business revolves around gastroenterology and pediatrics, with flagship products such as Compound Bismuth Aluminate Granules for gastric disorders. The company maintains large-scale manufacturing facilities that comply with Chinese Good Manufacturing Practice (GMP) standards. It serves as a vital production hub for the Dikang brand, supporting a wide distribution network across mainland China.